Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Net Asset Quality Index
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd net asset quality index. Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (600671) has a Net Asset Quality Index of 21.9% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥452.07 Million minus total liabilities of CN¥353.14 Million yields net assets of CN¥98.93 Million. A higher index indicates a stronger, lower-leverage balance sheet. See Hangzhou TianMuShan Pharmaceutical Enter book value and equity for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (1993–2025)
Net asset quality index of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd from 1993 to 2025. This chart shows how Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd's Net Asset Quality Index has evolved across 33 annual periods from 1993 to 2025. As of June 2026, the index stands at 21.9%, representing net assets of CN¥98.93 Million against total assets of CN¥452.07 Million CNY. Check asset allocation strategy of Hangzhou TianMuShan Pharmaceutical Enter to assess the company's strategic physical and investment asset allocation.
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Net Asset Quality Index by Year (1993–2025)
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd net asset quality index by year from 1993 to 2025. The table below presents the year-by-year Net Asset Quality Index for Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd from 1993 to 2025, covering 33 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 600671 market cap.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 21.3% | CN¥93.99 Million | CN¥442.03 Million | CN¥348.04 Million | ▲ +2.0 pp |
| 2024 | 19.3% | CN¥85.02 Million | CN¥441.46 Million | CN¥356.44 Million | ▲ +3.1 pp |
| 2023 | 16.2% | CN¥55.95 Million | CN¥346.29 Million | CN¥290.34 Million | ▲ +14.7 pp |
| 2022 | 1.5% | CN¥4.48 Million | CN¥299.84 Million | CN¥295.36 Million | ▼ -14.5 pp |
| 2021 | 16.0% | CN¥64.56 Million | CN¥402.65 Million | CN¥338.09 Million | ▼ -5.1 pp |
| 2020 | 21.1% | CN¥93.33 Million | CN¥442.51 Million | CN¥349.18 Million | ▼ -4.2 pp |
| 2019 | 25.3% | CN¥133.33 Million | CN¥526.93 Million | CN¥393.60 Million | ▲ +8.3 pp |
| 2018 | 17.0% | CN¥81.62 Million | CN¥480.62 Million | CN¥398.99 Million | ▼ -4.4 pp |
| 2017 | 21.4% | CN¥96.27 Million | CN¥450.44 Million | CN¥354.18 Million | ▼ -0.2 pp |
| 2016 | 21.6% | CN¥66.18 Million | CN¥306.19 Million | CN¥240.01 Million | ▼ -0.8 pp |
| 2015 | 22.4% | CN¥62.76 Million | CN¥280.38 Million | CN¥217.63 Million | ▼ -7.5 pp |
| 2014 | 29.8% | CN¥85.25 Million | CN¥285.64 Million | CN¥200.40 Million | ▲ +0.6 pp |
| 2013 | 29.3% | CN¥95.26 Million | CN¥325.27 Million | CN¥230.01 Million | ▼ -2.1 pp |
| 2012 | 31.3% | CN¥92.76 Million | CN¥295.92 Million | CN¥203.17 Million | ▼ -19.7 pp |
| 2011 | 51.1% | CN¥182.84 Million | CN¥357.84 Million | CN¥175.00 Million | ▲ +2.9 pp |
| 2010 | 48.2% | CN¥154.14 Million | CN¥319.79 Million | CN¥165.66 Million | ▼ -9.0 pp |
| 2009 | 57.2% | CN¥187.74 Million | CN¥328.27 Million | CN¥140.53 Million | ▼ -7.9 pp |
| 2008 | 65.1% | CN¥240.30 Million | CN¥369.08 Million | CN¥128.78 Million | ▼ -3.2 pp |
| 2007 | 68.3% | CN¥282.93 Million | CN¥414.09 Million | CN¥131.16 Million | ▲ +1.2 pp |
| 2006 | 67.1% | CN¥236.44 Million | CN¥352.47 Million | CN¥116.04 Million | ▲ +2.9 pp |
| 2005 | 64.2% | CN¥239.39 Million | CN¥372.71 Million | CN¥133.32 Million | ▼ -6.3 pp |
| 2004 | 70.5% | CN¥252.36 Million | CN¥357.85 Million | CN¥105.49 Million | ▲ +0.5 pp |
| 2003 | 70.0% | CN¥242.64 Million | CN¥346.52 Million | CN¥103.88 Million | ▲ +2.2 pp |
| 2002 | 67.8% | CN¥253.20 Million | CN¥373.53 Million | CN¥120.32 Million | ▲ +6.2 pp |
| 2001 | 61.6% | CN¥251.63 Million | CN¥408.75 Million | CN¥157.11 Million | ▼ -0.3 pp |
| 2000 | 61.9% | CN¥251.29 Million | CN¥405.88 Million | CN¥154.60 Million | ▼ -9.9 pp |
| 1999 | 71.8% | CN¥244.10 Million | CN¥339.78 Million | CN¥95.68 Million | ▼ -1.1 pp |
| 1998 | 73.0% | CN¥235.71 Million | CN¥323.01 Million | CN¥87.30 Million | ▼ -3.2 pp |
| 1997 | 76.2% | CN¥225.25 Million | CN¥295.69 Million | CN¥70.44 Million | ▼ -1.5 pp |
| 1996 | 77.7% | CN¥201.52 Million | CN¥259.33 Million | CN¥57.82 Million | ▲ +11.5 pp |
| 1995 | 66.2% | CN¥174.02 Million | CN¥263.02 Million | CN¥89.00 Million | ▲ +66.2 pp |
| 1994 | 0.0% | CN¥0.00 | CN¥192.12 Million | CN¥192.12 Million | ▼ -76.2 pp |
| 1993 | 76.2% | CN¥86.48 Million | CN¥113.50 Million | CN¥27.02 Million | — |